Chemical manufacturer Evonik has acquired a share into Friedrich Schiller University burn healing spinout JeNaCell.
The share was acquired as part of a series A round, the size of which was unannounced, which was also supported by state-backed investors Bmt Beteiligungsmanagement Thüringen and High-Tech-Gründerfonds, Thuringia Foundation for Technology, Innovation and Research and the Sparkasse Jena bank.
JeNaCell is developing a treatment for burn and chronic wounds which utilises nanocellulose. The material uses plant-based cellulose and nanostructured materials to produce an absorbent, tear-resistant, and moisture regulating wound dressing which is less painful than traditional dressings.
Bernhard Mohr, head of venture capital at Evonik, said: “JeNaCell is an outstanding strategic fit for Evonik. The company’s technology supplements our competencies in biotechnology and in the area of delivery systems for active medical ingredients.”
Evonik shares in JeNaCell’s healing
Jul 9, 2015 •
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
More universities adopt investor-friendly IP spinout terms
More universities adopt investor-friendly IP spinout terms
Academic institutions are taking new approaches to transferring intellectual property rights of university research in a bid to help spinouts attract investors.
Events
GCV Institute: CVC Investment Programs
May 21 -
May 22, 2024
Online
May 22, 2024
Online
Events
Global Energy Council Innovation Showcase
Jun 7, 2024
Online
Online
Events
Webinar: Moving the goalposts - How to invest in a changing world of sports
Jun 12, 2024
Online
Online
Events
GCV Symposium 2024
Jun 24 -
Jun 26, 2024
London (UK)
Jun 26, 2024
London (UK)
Events
Corporate Venture in Brasil 2024 – International Delegation to Brazil
Oct 28 -
Oct 30, 2024
São Paulo (Brazil)
Oct 30, 2024
São Paulo (Brazil)
Top News
test reg